AstraZeneca plc (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AZN New York 2834 https://www.astrazeneca.com/Home

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AstraZeneca plc (ADR)

The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study - Aug 22nd, 2019 5:18 am
AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study - Aug 21st, 2019 8:50 am
AstraZeneca's Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage Study - Aug 21st, 2019 7:04 am
UPDATE 2-AstraZeneca Imfinzi combination fails advanced lung cancer study - Aug 21st, 2019 5:35 am
AstraZeneca faces setback in lung cancer drug trial - Aug 21st, 2019 12:52 am
China adds 148 drugs to key insurance list - state media - Aug 20th, 2019 9:01 am
FARXIGA Met Primary Endpoint in Landmark Phase III DAPA-HF Trial for the Treatment of Patients With Heart Failure - Aug 20th, 2019 5:00 am
Sainsbury continues climb from 30-year low as FTSE 100 edges higher - Aug 20th, 2019 4:17 am
UPDATE 2-European shares end lower as Italy's political crisis weighs - Aug 20th, 2019 2:15 am
European shares rise for third straight session - Aug 20th, 2019 1:03 am
Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY - Aug 16th, 2019 9:28 am
AstraZeneca Calquence Gets FDA's Breakthrough Status for CLL - Aug 16th, 2019 8:33 am
Roche Receives FDA Nod for Rozlytrek in ROS1-positive NSCLC - Aug 16th, 2019 7:00 am
Agios Rides High on Tibsovo Sales Amid Acute Competition - Aug 15th, 2019 8:30 am
Merck's Cancer Immunotherapy Keytruda Continues to Aid Growth - Aug 15th, 2019 5:48 am
3 Healthcare Stocks at All-Time Highs: Are They Buys? - Aug 14th, 2019 6:15 am
CALQUENCE® (acalabrutinib) Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia - Aug 14th, 2019 6:00 am
LYNPARZA® (olaparib) Phase III Paola-1 Trial Met Primary Endpoint as 1st-line Maintenance Treatment With Bevacizumab for Advanced Ovarian Cancer - Aug 14th, 2019 5:00 am
AstraZeneca Success On Prostate Cancer Drug Lowers Enthusiasm For Clovis - Aug 13th, 2019 8:58 am
Spectrum Pharma's (SPPI) Loss Narrows in Q2, Stock Rises - Aug 12th, 2019 8:47 am